Location: Greenwich, CT
CIK: 0001577524 · Show all filings
Period: Q4 2013 (Next →)
Filing Date: Feb 14, 2014
Total Value: $267M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARIAD PHARMACEUTICALS INC | 12,000,000 | $81.84M | 30.6% | $6.82 | — | COM | 04033A100 |
| DGX | QUEST DIAGNOSTICS INC | 700,000 | $37.48M | 14.0% | $46.46 | 0.0% | COM | 74834L100 |
| — | IDENIX PHARMACEUTICALS INC | 5,050,100 | $30.2M | 11.3% | $5.98 | — | COM | 45166R204 |
| — | VIVUS INC | 2,573,943 | $23.37M | 8.8% | $9.08 | — | COM | 928551100 |
| MRK | MERCK & CO INC NEW | 400,000 | $20.02M | 7.5% | $31.29 | 0.0% | COM | 58933Y105 |
| — | MALLINCKRODT PUB LTD CO | 280,000 | $14.63M | 5.5% | $52.26 | — | SHS | G5785G107 |
| BMY | BRISTOL MYERS SQUIBB CO | 250,000 | $13.29M | 5.0% | $34.16 | 0.0% | COM | 110122108 |
| ABBV | ABBVIE INC | 250,000 | $13.2M | 4.9% | $30.39 | 0.0% | COM | 00287Y109 |
| PFE | PFIZER INC | 410,000 | $12.56M | 4.7% | $17.62 | 0.0% | COM | 717081103 |
| — | REPROS THERAPEUTICS INC | 459,508 | $8.409M | 3.1% | $18.30 | — | COM NEW | 76028H209 |
| — | BIO-REFERENCE LABS INC | 285,300 | $7.287M | 2.7% | $25.54 | — | COM $.01 NEW | 09057G602 |
| — | AVEO PHARMACEUTICALS | 2,570,759 | $4.73M | 1.8% | $1.84 | — | COM | 053588109 |